Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
The prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute n...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2019-09-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdf |
id |
doaj-2ce04587d1f44d1a9421f062fafb651c |
---|---|
record_format |
Article |
spelling |
doaj-2ce04587d1f44d1a9421f062fafb651c2021-04-02T20:59:44ZengConcilium MedicumКардиоСоматика2221-71852658-57072019-09-01103132910.26442/22217185.2019.3.19057241560Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologistElena V. Reznik0Semen Yu. Soltis1Dmitrii V. Ustiuzhanin2Igor G. Nikitin3Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityNational Medical Research Center of CardiologyPirogov Russian National Research Medical UniversityThe prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute number of the patients in whom there is a lack of efficacy of optimally prescribed drug therapy. These patients are considering initiating cardiac resynchronization therapy (CRT). CRT is recommended for the patients with chronic heart failure II-IV functional class with severe left ventricular systolic dysfunction and prolonged QRS complex. Despite careful selection of patients for CRT implantation, the device does not lead to the expected result in one third of cases. To increase the effectiveness of this intervention, the procedure should be performed in accordance with current guidelines only for compliant patients who have been at least 3 months on selected optimal drug therapy, should use the optimal strategies and modes of stimulation and the adequate drug support after the intervention. The number of patients with long-term use of CRT is constantly growing. More and more patients with installed devices come into the field of vision of general practitioners and cardiologists of ambulatory clinics and hospitals, for whom it is extremely important to understand the specifics of the methods and tactics of managing such patients. This publication is dedicated to this.https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdfchronic heart failurecardiac resynchronization therapyimplantable cardioverter-defibrillatoroptimal drug therapyprognosisquality of lifeleft ventricular ejection fraction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elena V. Reznik Semen Yu. Soltis Dmitrii V. Ustiuzhanin Igor G. Nikitin |
spellingShingle |
Elena V. Reznik Semen Yu. Soltis Dmitrii V. Ustiuzhanin Igor G. Nikitin Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist КардиоСоматика chronic heart failure cardiac resynchronization therapy implantable cardioverter-defibrillator optimal drug therapy prognosis quality of life left ventricular ejection fraction |
author_facet |
Elena V. Reznik Semen Yu. Soltis Dmitrii V. Ustiuzhanin Igor G. Nikitin |
author_sort |
Elena V. Reznik |
title |
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
title_short |
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
title_full |
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
title_fullStr |
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
title_full_unstemmed |
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
title_sort |
cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist |
publisher |
Concilium Medicum |
series |
КардиоСоматика |
issn |
2221-7185 2658-5707 |
publishDate |
2019-09-01 |
description |
The prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute number of the patients in whom there is a lack of efficacy of optimally prescribed drug therapy. These patients are considering initiating cardiac resynchronization therapy (CRT). CRT is recommended for the patients with chronic heart failure II-IV functional class with severe left ventricular systolic dysfunction and prolonged QRS complex. Despite careful selection of patients for CRT implantation, the device does not lead to the expected result in one third of cases. To increase the effectiveness of this intervention, the procedure should be performed in accordance with current guidelines only for compliant patients who have been at least 3 months on selected optimal drug therapy, should use the optimal strategies and modes of stimulation and the adequate drug support after the intervention. The number of patients with long-term use of CRT is constantly growing. More and more patients with installed devices come into the field of vision of general practitioners and cardiologists of ambulatory clinics and hospitals, for whom it is extremely important to understand the specifics of the methods and tactics of managing such patients. This publication is dedicated to this. |
topic |
chronic heart failure cardiac resynchronization therapy implantable cardioverter-defibrillator optimal drug therapy prognosis quality of life left ventricular ejection fraction |
url |
https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdf |
work_keys_str_mv |
AT elenavreznik cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist AT semenyusoltis cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist AT dmitriivustiuzhanin cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist AT igorgnikitin cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist |
_version_ |
1721545832064352256 |